Internal Medicine, Cardiovascular Disease · Buffalo, NY
NPI
1891787685
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
4
Medicare group memberships
Hospitals
4
Hospital affiliations
565 Abbott Rd
Buffalo, NY, 14220
Phone (716) 826-7000
Groups this clinician bills Medicare through
Medicare paid, 2024
$232K
4,101 services
Medicare patients, 2024
1,532
Average age 75
Drug cost, 2024
$1.6M
15,072 prescriptions
Company payments, 2025
$136
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eugene M Spear was code 99214 (office e&m - established), 1,234 times for 799 patients. In total Eugene M Spear billed 4,101 services in 66 codes, and Medicare paid $232K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,234 | 799 | $87.97 | $109K |
| 93010 Electrocardiogram | Facility | 758 | 588 | $6.14 | $4,657 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 693 | 552 | $12.80 | $8,872 |
| 93306 Echocardiography (TTE/TEE) | Facility | 273 | 266 | $54.57 | $15K |
| 93000 Electrocardiogram | Office | 202 | 165 | $10.56 | $2,133 |
| 99223 Hospital E&M - Initial | Facility | 149 | 127 | $137.91 | $21K |
| 99233 Hospital E&M - Subsequent | Facility | 131 | 65 | $96.19 | $13K |
| 92960 Cardiovascular | Facility | 75 | 57 | $85.53 | $6,414 |
| 93280 External Electrocardiographic Monitoring | Office | 72 | 67 | $25.69 | $1,850 |
| 99238 Hospital Discharge Management | Facility | 50 | 46 | $65.19 | $3,260 |
| 93227 Electrocardiogram | Facility | 37 | 37 | $15.04 | $557 |
| 93350 Echocardiography (TTE/TEE) | Facility | 35 | 35 | $52.99 | $1,855 |
| 99232 Hospital E&M - Subsequent | Facility | 29 | 19 | $64.58 | $1,873 |
| 99213 Office E&M - Established | Office | 29 | 29 | $61.83 | $1,793 |
| 99204 Office E&M - New | Office | 28 | 28 | $112.93 | $3,162 |
By year: 2022 $263K for 3,609 services; 2023 $260K for 3,209 services; 2024 $232K for 4,101 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eugene M Spear prescribed most often to Medicare patients was Carvedilol, with 1,468 prescriptions and refills. In total Eugene M Spear wrote 15,072 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carvedilol Generic | 1,468 | 4,135 | 451 | $14K |
| Amlodipine Besylate Generic | 1,024 | 2,909 | 353 | $8,863 |
| Atorvastatin Calcium Generic | 966 | 2,670 | 294 | $11K |
| Metoprolol Succinate Generic | 804 | 2,138 | 245 | $12K |
| Potassium Chloride Generic | 738 | 1,930 | 271 | $13K |
| Furosemide Generic | 729 | 1,952 | 267 | $4,852 |
| Eliquis Apixaban | 699 | 1,417 | 191 | $765K |
| Metoprolol Tartrate Generic | 684 | 1,921 | 216 | $6,180 |
| Lisinopril Generic | 630 | 1,831 | 200 | $5,759 |
| Losartan Potassium Generic | 609 | 1,693 | 202 | $7,204 |
| Triamterene-Hydrochlorothiazid Triamterene/Hydrochlorothiazid | 485 | 1,404 | 165 | $4,680 |
| Amiodarone Hcl Generic | 478 | 1,257 | 177 | $7,113 |
| Clopidogrel Clopidogrel Bisulfate | 380 | 1,072 | 118 | $5,684 |
| Valsartan Generic | 340 | 1,008 | 113 | $13K |
| Xarelto Rivaroxaban | 326 | 708 | 85 | $384K |
Brand drugs: - claims; generic drugs: 13,520 claims; opioid claims: 26.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eugene M Spear $136 ($136 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbott Laboratories with $136.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 7 | $136 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.